Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,015,258 |
|
|||||
| News | - | ||||||
| Day High | 7.88 | Low High |
|||||
| Day Low | 7.51 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Voyager Therapeutics Inc | VYGR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.14 | -1.81% | 7.60 | 16:31:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.75 | 7.51 | 7.88 | 7.55 | 7.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,772 | 1,015,258 | $ 7.68 | $ 7,797,672 | - | 6.06 - 14.3398 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:55:08 | 10 | $ 7.60 | USD |
Voyager Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 409.43M | 54.30M | - | 250.01M | 132.33M | 2.44 | 3.09 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Voyager Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VYGR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.90 | 9.02 | 7.51 | 8.18 | 521,670 | -1.30 | -14.61% |
| 1 Month | 10.40 | 10.66 | 7.51 | 9.26 | 649,267 | -2.80 | -26.92% |
| 3 Months | 7.52 | 10.66 | 7.08 | 8.91 | 646,800 | 0.08 | 1.06% |
| 6 Months | 7.50 | 11.72 | 6.06 | 8.74 | 628,349 | 0.10 | 1.33% |
| 1 Year | 7.97 | 14.3398 | 6.06 | 9.50 | 549,309 | -0.37 | -4.64% |
| 3 Years | 4.56 | 14.3398 | 2.46 | 5.73 | 891,793 | 3.04 | 66.67% |
| 5 Years | 19.23 | 28.79 | 2.46 | 7.38 | 682,344 | -11.63 | -60.48% |
Voyager Therapeutics Description
| Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies. |
